GENinCode (STU:9PL) Days Inventory: 30.01 (As of Dec. 2025) — 89% Above Median


What is GENinCode Days Inventory?

GENinCode STU:9PL Days Inventory is 30.01 as of Dec. 2025, which is 89% above its 10-year median of 15.84. The stock has 4 warning signs investors should review. Among 178 Medical Diagnostics & Research companies, GENinCode ranks better than 78.65% on this metric.

Days Inventory is also known as Days Sales of Inventory (DSI). GENinCode's Average Total Inventories for the six months ended in Dec. 2025 was €0.10 Mil. GENinCode's Cost of Goods Sold for the six months ended in Dec. 2025 was €0.59 Mil. Hence, GENinCode's Days Inventory for the six months ended in Dec. 2025 was 30.01.

The historical rank and industry rank for GENinCode's Days Inventory or its related term are showing as below:

STU:9PL' s Days Inventory Range Over the Past 10 Years
Min: 7.78   Med: 15.84   Max: 30.06
Current: 28.12

During the past 7 years, GENinCode's highest Days Inventory was 30.06. The lowest was 7.78. And the median was 15.84.

STU:9PL's Days Inventory is ranked better than
78.65% of 178 companies
in the Medical Diagnostics & Research industry
Industry Median: 68.88 vs STU:9PL: 28.12

GENinCode's Days Inventory declined from Dec. 2024 (30.05) to Dec. 2025 (30.01).

Inventory Turnover measures how fast the company turns over its inventory within a year. GENinCode's Inventory Turnover for the six months ended in Dec. 2025 was 6.08.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. GENinCode's Inventory-to-Revenue for the six months ended in Dec. 2025 was 0.06.


GENinCode  (STU:9PL) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

GENinCode's Inventory Turnover for the six months ended in Dec. 2025 is calculated as

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

GENinCode's Inventory to Revenue for the six months ended in Dec. 2025 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.


GENinCode Days Inventory Related Terms


GENinCode Days Inventory Historical Data

* Premium members only.

The historical data trend for GENinCode's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

GENinCode Days Inventory Chart

GENinCode Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Days Inventory
Get a 7-Day Free Trial 9.95 7.76 16.72 29.65 29.48

GENinCode Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Days Inventory Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 22.42 22.37 30.05 27.19 30.01

STU:9PL vs TMO, DHR, IDXX: Days Inventory Comparison

For the Diagnostics & Research subindustry, GENinCode's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


GENinCode Days Inventory vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, GENinCode's Days Inventory distribution charts can be found below:

* The bar in red indicates where GENinCode's Days Inventory falls into.



GENinCode Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

GENinCode's Days Inventory for the fiscal year that ended in Dec. 2025 is calculated as

Days Inventory (A: Dec. 2025 )
=Average Total Inventories / Cost of Goods Sold*Days in Period
=( (Total Inventories (A: Dec. 2024 ) + Total Inventories (A: Dec. 2025 )) / count ) / Cost of Goods Sold (A: Dec. 2025 )*Days in Period
=( (0.152 + 0.083) / 2 ) / 1.455*365
=0.1175 / 1.455*365
=29.48

GENinCode's Days Inventory for the quarter that ended in Dec. 2025 is calculated as:

Days Inventory (Q: Dec. 2025 )
=Average Total Inventories / Cost of Goods Sold*Days in Period
=( (Total Inventories (Q: Jun. 2025 ) + Total Inventories (Q: Dec. 2025 )) / count ) / Cost of Goods Sold (Q: Dec. 2025 )*Days in Period
=( (0.112 + 0.083) / 2 ) / 0.593*365 / 2
=0.0975 / 0.593*365 / 2
=30.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Days Inventory →
What does a Days Inventory of 30.01 mean?
GENinCode (STU:9PL) has a Days Inventory of 30.01 as of Dec. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on GENinCode and its competitors. This is 89% above median its historical median of 15.84. Over the past decade, GENinCode's Days Inventory has ranged from 7.78 to 30.06. According to the industry distribution chart, GENinCode ranks #38 out of 178 companies in the Medical Diagnostics & Research industry, placing it in the top 21.3%.
Is GENinCode's Days Inventory too high?
GENinCode's current Days Inventory of 30.01 is 89% above median its 10-year median of 15.84. Over the past 10 years, this metric has ranged from a low of 7.78 to a high of 30.06. The Medical Diagnostics & Research industry median Days Inventory is 68.88. GENinCode's value of 30.01 is 56.4% below this industry median. Based on the distribution chart, GENinCode ranks #38 out of 178 companies in the Medical Diagnostics & Research industry, which is in the top quartile — a strong position relative to peers.
How does GENinCode's Days Inventory compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, GENinCode ranks #38 out of 178 companies for Days Inventory. This places GENinCode in the top 21% of its industry — outperforming the majority of peers. The industry median Days Inventory is 68.88. GENinCode's value of 30.01 is 56.4% below this benchmark. Historically, GENinCode's own Days Inventory has ranged from 7.78 to 30.06 over the past decade. While the company's 10-year median is 15.84 vs. the industry median of 68.88, GENinCode has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Medical Diagnostics & Research company?
The median Days Inventory among Medical Diagnostics & Research companies is 68.88, based on 178 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. GENinCode's current Days Inventory of 30.01 is 56.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on GENinCode and its competitors. For the Medical Diagnostics & Research industry, the median Days Inventory is 68.88 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. GENinCode's current Days Inventory is 30.01, which is 89% above median its own 10-year median of 15.84. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GENinCode stock overvalued right now?
GENinCode (STU:9PL) has a current Days Inventory of 30.01. The current Days Inventory is 30.01, which is 89% above median its 10-year median of 15.84 and 56.4% below the Medical Diagnostics & Research industry median of 68.88. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For GENinCode (STU:9PL), the current Days Inventory is 30.01 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

GENinCode Business Description

Other Exchanges GENI:UK
Address Oxford Science Park, John Eccles House, Robert Robertson Avenue, Oxford, GBR, OX4 4GP
GENinCode PLC principal activity is the development and commercialisation of clinical genetic tests, to provide predictive analysis of risk to a patient's health based on their genes. The company has one operating segment. The company has presence in Spain, UK, United States, Italy, Germany, and Rest of World. The company generates majority of revenue from Spain. Its commercial products are CE-Marked, with CARDIO inCode, THROMBO inCode, and LIPID inCode.